An observational study in Scabies, sponsored by Seton Healthcare Family. Completed at 5 sites in United States. Per ClinicalTrials.gov, last updated 2018-07-03.
Sponsored by Seton Healthcare Family · Observational
Among 10 studies in Scabies with a site in United States — 1 open to participants now, 1 under way, none of them phase 3. Scabies · United States.
Among the 10 studies in Scabies with a site in United States, this one is one of 2 that started in 2014, is the only observational one, and was the 2nd registered.
51 studies on the registry are indexed under Scabies; 10 are open to participants now.
This study's enrollment of 17 is below the median of 775 across 10 observational studies indexed under Scabies.
Browse Scabies studies →1 of the 10 studies in Scabies with a site in United States is open now, in 1 country. Each count lists the studies.
Of the 4 Scabies studies recruiting now, 3 (75%) set no upper age limit and 1 (25%) stop at 75 or younger; 3 take children under 18; 3 take healthy volunteers.
This study: all sexes · healthy volunteers too.
The full table on the hub →10 studies; the count open now beside each. This study's row is marked.
First in 2014; this study’s year is marked. 2 started in 2014.
Median enrollment 200 across the 9 interventional studies, 17 across the 1 observational. Of the 9 that completed or were terminated, 6 (67%) have results posted.
8 of 10 have an industry lead sponsor. The 9 most frequent:
Seton Healthcare Family is the lead sponsor of 21 studies on the registry; none are open to participants now.
Seton Healthcare Family has 1 study filed under Scabies — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 10 studies in Scabies with a site in United States, from their registry updates:
Nothing recorded among them since 2026-09-25.
The main objective of this study is to identify unique DNA sequences within the genome of human scabies that can be utilized to identify the parasite through PCR.
The main objective of this proposed study is to identify unique DNA sequences within the genome of human scabies that can be utilized to identify the parasite through polymerase chain reaction or PCR. The goal of the project is to design an assay that can distinguish samples from skin scrapings containing scabies mites, eggs, or fecal material confirmed by clinic based microscopic evaluation (gold standard) from negative controls (i.e. scrapings for tinea and/or demodex folliculitis) that do not contain Sarcoptes scabiei. We hypothesize that specifically amplifying the unique regions of the Scabies genome using PCR can serve as a means to diagnosis infestations in humans. To address this question, we will optimize PCR amplification of known scabies samples then apply our procedure to DNA extracted from patient samples.
Patients will be recruited upon identifying of scabies by microscopy or when a scraping is performed for suspected tinea or demodex folliculitis
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Male/Female of all ages whose standard clinical treatment produces one or more of the following:
Exclusion Criteria:
Skin scrapings that are positive for scabies
collect negative controls from patients in whom tinea (superficial fungal infection) was clinically suspected. Samples from patients with demodex folliculitis (a mite that is commonly found in oil glands on the face) are also intended to be used as negative controls as well.
Identification of DNA sequences within scabies that can be used to identify the parasite through PCR
Time frame: 1 year
Plan to share: No
No publications or documents are linked to this record.
Ran from Oct 2014 to primary completion in Aug 2017, 34 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jun 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Seton Healthcare Family